Mpox Resurgence: A Multifaceted Analysis for Global Preparedness DOI Creative Commons
Fatouma Mohamed Abdoul‐Latif, Ayoub Ainane,

Houda Mohamed

et al.

Viruses, Journal Year: 2024, Volume and Issue: 16(11), P. 1737 - 1737

Published: Nov. 5, 2024

This study provides an in-depth analysis of mpox, encompassing its history, characteristics, epidemiology, diagnostics, treatment options, and the ongoing evolution virus transmission dynamics. Mpox, though once successfully eradicated, has re-emerged with new modes a broader host range. Genomic analyses have revealed virus's adaptability, posing challenges for diagnostics vaccine efficacy. The epidemiology shifted from sporadic zoonotic in rural Africa to significant presence urban areas, particularly impacting high-risk populations. Advancements therapeutics offer hope, but persist. work underscores critical need enhanced surveillance, vaccination strategies, continued research bolster global health systems preparedness future outbreaks.

Language: Английский

Mpox 2024: New variant, new challenges, and the looming pandemic DOI Creative Commons
Amogh Verma, Mahalaqua Nazli Khatib, Gopal Ashish Sharma

et al.

Clinical Infection in Practice, Journal Year: 2024, Volume and Issue: unknown, P. 100394 - 100394

Published: Oct. 1, 2024

Language: Английский

Citations

9

Mpox Virus as a Global Public Health Emergency: A Scoping Review DOI Creative Commons
Sathish Sankar, Pachamuthu Balakrishnan, Yean K. Yong

et al.

Canadian Journal of Infectious Diseases and Medical Microbiology, Journal Year: 2025, Volume and Issue: 2025(1)

Published: Jan. 1, 2025

The monkeypox (Mpox) virus has emerged as a global public health emergency of international concern recently. that was endemic in West and Central Africa now been reported with chains transmission to several countries. A scoping review carried out from the relevant literature available PubMed, Scopus Web Science. This comprehensive analysis describes epidemiology, pathogenesis, clinical manifestations, complications including secondary bacterial infections, diagnosis, treatment vaccination. article underscores significance key viral immune mediators infection discusses updated recommendations on therapeutic strategies

Language: Английский

Citations

1

Interdisciplinary Approach to Monkeypox Prevention: Integrating Nanobiosensors, Nanovaccines, Artificial Intelligence, Visual Arts, and Social Sciences DOI Creative Commons
Vishal Chaudhary,

Lucky Lucky,

Harsh Sable

et al.

Small Structures, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 19, 2025

To effectively address crisis emergence of new virus such as monkeypox, a collective and collaborative effort between scientists, engineers, innovators, artists from all ages, regions, diverse fields is required. This review explores holistic approach to addressing the monkeypox by integrating nanobiosensors, artificial intelligence, visual arts, humanities, social sciences. Traditional diagnostic methods are often limited time, accessibility, accuracy, but advancement point‐of‐care smart nanobiosensors offers promising shift toward rapid, precise, accessible diagnostics. They enhance ability screen, diagnose, monitor infections efficiently, contributing better disease management. Beyond technological innovation, essential role sciences in fostering public engagement, understanding, acceptance tools emphasized. Visual arts can illustrate scientific concepts, making them more relatable, while storytelling through various media reduce stigma promote preventive measures. Social provide insights into cultural attitudes, behaviors, health challenges, ensuring that solutions integrated communities. By combining these disciplines, this presents comprehensive framework for resilient global system aligns with One Health principles, emphasizing interconnectedness human, animal, environmental health.

Language: Английский

Citations

1

The resurgence of monkeypox clade Ib: a global health emergency and concern DOI
Suresh Kumar, Gunasekaran Subramaniam,

K. J. Senthil Kumar

et al.

Archives of Virology, Journal Year: 2025, Volume and Issue: 170(4)

Published: March 21, 2025

Language: Английский

Citations

1

Monkeypox 2024 outbreak: Fifty essential questions and answers DOI Open Access
Beatriz Cabanillas, Giuseppe Murdaca, Amir Guemari

et al.

Allergy, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 4, 2024

Abstract As the world still vividly recalls previous monkeypox (mpox) outbreak that impacted over 120 countries worldwide with more than 99,000 cases in 2022, we are now facing a second wave of infections from virus (MPXV), characterized by an exponential increase cases. The current 2024 has already recorded 20,000 Africa, marking dramatic escalation compared to outbreaks. predominance newly identified clade Ib variant, first detected Democratic Republic Congo (DRC) and across multiple African nations beyond, underscores its enhanced transmissibility potential for international spread, evidenced Sweden Thailand. World Health Organization (WHO) declared on August 14, 2024, mpox Public Emergency International Concern (PHEIC), calling heightened global public health measures. ongoing pattern unusual, frequent, extensive outbreaks implications poses significant questions. This review addresses, format 50 questions answers, outbreak, detailing characteristics, epidemiological data, impact It comprehensively explores critical related MPXV virological immunological response, clinical manifestations, epidemiology, diagnostics, available treatments. also documents evolving challenges posed highlighting scale, response.

Language: Английский

Citations

6

Innate Immune Response to MPOX Infection: Mechanisms and Immune Escape DOI Creative Commons

Reza Parnian,

Fatemeh Heydarifard,

F Mousavi

et al.

Journal of Innate Immunity, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 13, 2024

The re-emergence of the Mpox (formerly monkeypox) in 2022 non-endemic countries has raised many concerns for global health due to its high transmissibility and mortality rate. A major challenge fighting is ability evade host's innate immune system, which first line defense against viral infections. encodes various proteins that interfere with key antiviral pathways mechanisms, such as nuclear factor kappa B (NF-κB) signaling, cytokine production, complement inflammasome activation, chemokine binding. These modulate expression function mediators, interferons, interleukins, toll-like receptors, impair recruitment activation cells, natural killer cells. By suppressing or altering these responses, enhances replication infection host tissues organs, leading systemic inflammation, tissue damage, organ failure. This study reveals new insights into molecular cellular interactions between host’s immunity identifies potential targets strategies interventions.

Language: Английский

Citations

5

Viral Replication Regulated by Radiation DOI Creative Commons
Zhao Yu, Yingyi Zhang, Yang Liu

et al.

IntechOpen eBooks, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 12, 2025

Viruses are widely present in nature and can infect eukaryotic cells, producing a variety of biological effects. Several viruses capable coexisting with human cells over the long term, it has been proven that these possess carcinogenic properties. Radiation therapy is common method used for treating tumors. Under influence radiation, infected tumor uninfected exhibit different pathological characteristics treatment outcomes. Herein, this chapter, we discuss impact five on radiation therapy, including coronavirus disease-2019 (COVID-19), hepatitis B virus (HBV), papillomavirus (HPV), monkeypox virus, avian influenza virus. We hope by summarizing relationship between viral replication provide novel insight future treatments.

Language: Английский

Citations

0

Genomic Variation and Impact on the Proteins of Mpox Virus DOI Creative Commons
Hao Chen, Yang Xu, Yafei Li

et al.

Journal of Infection, Journal Year: 2025, Volume and Issue: 90(4), P. 106452 - 106452

Published: Feb. 26, 2025

Language: Английский

Citations

0

Structure-based drug designing for potential antiviral activity of selected natural product against Monkeypox (Mpox) virus and its host targets DOI

Vimal K. Maurya,

Swatantra Kumar,

Shivani Maurya

et al.

VirusDisease, Journal Year: 2024, Volume and Issue: 35(4), P. 589 - 608

Published: Nov. 29, 2024

Language: Английский

Citations

2

Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response DOI Creative Commons
Elisa Petruccioli,

Settimia Sbarra,

Serena Vita

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(9), P. 964 - 964

Published: Aug. 26, 2024

Monkeypox (Mpox) is a zoonotic disease caused by monkeypox virus (MPXV), an Orthopoxvirus (OPXV). Since we are observing the first MPXV outbreak outside African continent, general population probably does not have pre-existing memory response for but may immunity against previous smallpox vaccine based on live replicating Vaccinia strain (VACV). Using whole blood platform, aim to study MPXV- T-cell-specific in Mpox-cured subjects.

Language: Английский

Citations

0